WallStreetZenWallStreetZen

NASDAQ: ADIL
Adial Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ADIL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$5.1M
Current Profit Margin
0%

ADIL Return on Equity

Current Company
-183.3%
Current Industry
-63.5%
Current Market
188%
ADIL's Return on Equity (-183.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ADIL announces earnings.

ADIL Return on Assets

Current Company
-134.1%
Current Industry
2.9%
ADIL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ADIL Return on Capital Employed

Current Company
-125.46%
Current Industry
19.5%
ADIL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ADIL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ADIL$0.00-$5.12M-$5.12MN/AN/A
NTBL$310.00k-$10.28M-$11.15M-11.93%N/A
CYCN$0.00-$5.62M-$5.26M-100.00%N/A
VIRI$0.00-$5.30M-$5.30MN/AN/A
KZIA$15.13kN/A-$10.33M-65.97%N/A
View Top Biotech Stocks

ADIL earnings dates

Next earnings date
May 10, 2024

Adial Pharmaceuticals Earnings & Revenue FAQ

What were ADIL's earnings last quarter?

On Invalid Date, Adial Pharmaceuticals (NASDAQ: ADIL) reported Q4 2023 earnings per share (EPS) of -$0.74, up 73.29% year over year. Total Adial Pharmaceuticals earnings for the quarter were -$1.92 million. In the same quarter last year, Adial Pharmaceuticals's earnings per share (EPS) was -$2.77.

If you're new to stock investing, here's how to buy Adial Pharmaceuticals stock.

What was ADIL's earnings growth in the past year?

As of Q2 2024, Adial Pharmaceuticals's earnings has grown year over year. Adial Pharmaceuticals's earnings in the past year totalled -$5.12 million.

What is ADIL's earnings date?

Adial Pharmaceuticals's earnings date is Invalid Date. Add ADIL to your watchlist to be reminded of ADIL's next earnings announcement.

What was ADIL's revenue last quarter?

On Invalid Date, Adial Pharmaceuticals (NASDAQ: ADIL) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Adial Pharmaceuticals's revenue was $0.00.

What was ADIL's revenue growth in the past year?

As of Q2 2024, Adial Pharmaceuticals's revenue has grown null year over year. Adial Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.